Idera Pharmaceuticals, Inc.

符号: IDRA

NASDAQ

0.425

USD

今天的市场价格

-97.1145
市盈率
7.8442
PEG比率
26.50M
MRK市值
0.00%
DIV收益率

Idera Pharmaceuticals, Inc. (IDRA) 财务报表

Q: 什么是 Idera Pharmaceuticals, Inc. (IDRA) 总资产是多少？

Idera Pharmaceuticals, Inc. (IDRA) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Idera Pharmaceuticals, Inc. (IDRA). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Idera Pharmaceuticals, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
balance-sheet.row.cash-and-short-term-investments	65.44	12	32.5	37.7	42.8	71.4	112.6	109	60.2	41.2	29.4	10.1	24.6	34.6	31.7	55.6	23.7	38.2	8.4	14.4	13.7	19.2	31.8	3.5	2.6	5.6	2.2	16.4	5.3
balance-sheet.row.short-term-investments	0	0	0	4.5	2.8	0	0	28.3	33.6	21.3	3.1	0	0	17.6	6.3	10.4	11.2	13.6	7.4	9.4	6.1	14.6	10.9	2	0	0	0	3.8	0
balance-sheet.row.net-receivables	8.38	4.2	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0.5	0.6	0.4	0.2	0.3	0.2	0.4	0.3	0.3	1.2	1.2	0.5	0	0
balance-sheet.row.inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	5.35	1.6	1.5	3.6	3.5	1.4	4	2	3.1	1.2	0.9	0.2	0.3	1	1	0.9	0.7	0.4	0.5	0.3	0.1	0.2	0.1	0.1	0.1	0.1	1	2.1	0.9
balance-sheet.row.total-current-assets	79.16	17.9	34	41.4	46.3	72.8	116.6	111	63.2	42.4	30.3	10.3	24.8	35.6	37.3	57	25	39	9	15	14	19.8	32.2	3.9	3.9	6.9	3.7	18.5	6.2
balance-sheet.row.property-plant-equipment-net	2.27	0.5	0.8	1	1.2	0.2	1.5	1.9	1.7	1.3	0.1	0.2	0.5	0.9	1.4	1.8	2	0.6	0.4	0.4	0.4	0.5	0.1	0.1	6.4	8.8	19.2	15.6	9.1
balance-sheet.row.goodwill	25.66	11.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	201.67	71.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	227.33	82.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	27	7.3	6.2	0	0	0	8.5	0	0	0	0	0	0	941.1	0	0	0	0	0	0	1.7
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	0.82	0	0.1	0.1	0.1	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.6	0.7	0.9	0.5	0	0	-940.1	0	6	1.6	0.9	12.1	7.4	2.6
balance-sheet.row.total-non-current-assets	230.43	83.2	0.8	1	1.2	0.2	1.8	2.2	29	9	6.6	0.5	0.8	1.2	10.4	2.4	2.7	1.5	0.9	0.4	0.4	1.5	0.1	6.1	8	9.6	31.3	23	13.4
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	309.59	101.1	34.9	42.4	47.5	73	118.4	113.2	92.3	51.4	36.9	10.8	25.6	36.9	47.6	59.4	27.7	40.5	10	15.4	14.4	21.2	32.3	10	11.9	16.5	35.1	41.5	19.6
balance-sheet.row.account-payables	15.52	5.2	0.6	0.3	0.5	1.1	1.3	0.6	1.2	2.5	0.9	1.1	1.2	1.8	1.2	1.3	1.2	1.2	0.5	0.4	0.7	0.8	0.5	1.1	1.6	2.4	8.1	4.1	2.1
balance-sheet.row.short-term-debt	0.92	0.2	0.2	0.2	0.2	0	0.2	0.3	0.3	0.1	0	0	0	0	0	0	0.3	0	0	0	1.3	0	3.4	6	6.1	6.1	7.9	1.3	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	1.42	0.3	0.5	0.8	0.9	0	0	0.2	0.5	0.7	0	0	0	0	0	0	0.9	5	5	0	0	1.3	1.3	9.4	7.8	1.8	53.3	9	1.1
Deferred Revenue Non Current	0	0	0	0	0	0	0	0.2	1.3	0	0	0	0	0	0.1	12.2	9.9	15249.6	1229.5	523.7	651.2	363.4	26129.7	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	10.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	46.81	16	4.1	6.5	53.9	7.9	8	7.4	4.3	4.5	3.5	3	4.9	1.8	0.9	1.2	1.7	0.9	1.3	1.3	1.1	0.8	-3097.6	1.1	2.5	4.1	11.9	4.3	3.9
balance-sheet.row.total-non-current-liabilities	142.95	40.8	0.5	126.5	4.1	0	0.6	0.5	1.9	1	0	0.1	7.5	0.2	0.3	12.4	10.9	20.3	6.3	0.8	0.7	1.7	27.4	9.4	7.8	1.8	53.3	9	1.2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2.33	0.6	0.8	0.9	1.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	206.21	62.2	5.4	133.6	58.7	9	10.7	9.9	8.7	8	4.4	4.2	13.6	3.8	14.5	37.2	20	28.3	10.3	2.6	3.9	3.8	32.3	17.5	18	14.3	81.1	18.7	7.2
balance-sheet.row.preferred-stock	55.2	34.3	0	0	0	0	0	0	0	0	11	9.6	5.9	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0
balance-sheet.row.common-stock	0.12	0	0.1	0	0	0	0.2	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-3032.5	-758.8	-735.5	-833.6	-720.9	-664.4	-604.5	-538.5	-500.1	-451.5	-412.9	-394.7	-375.4	-351.6	-333.7	-341.2	-342.7	-329.5	-313	-299.3	-283.9	-261.1	-273.9	-260.2	-253.2	-238.4	-218.7	-149.2	-102.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	-0.02	0	0	0	-0.8	-0.7	0	0	-0.1	0	0	-3.2	0	0	0	0	0	0	-0.1	0	0	0	-5.3	-5.3	-14.7	-13.8	-11.1	-6.6	-4.2
balance-sheet.row.other-total-stockholders-equity	3053.47	736.4	764.9	742.3	710.5	729	712	641.7	583.7	494.9	434.3	394.8	381.5	384.7	366.8	363.4	350.4	341.7	312.6	312	294.4	278.6	272.7	257.9	261.8	254.5	183.7	178.6	118.9
balance-sheet.row.total-stockholders-equity	76.27	11.8	29.5	-91.2	-11.2	64	107.7	103.3	83.6	43.4	32.5	6.6	12	33.1	33.1	22.2	7.7	12.2	-0.3	12.8	10.5	17.4	0	-7.5	-6.1	2.2	-46	22.9	12.4
balance-sheet.row.total-liabilities-and-stockholders-equity	282.48	74	34.9	42.4	47.5	73	118.4	113.2	92.3	51.4	36.9	10.8	25.6	36.9	47.6	59.4	27.7	40.5	10	15.4	14.4	21.2	32.3	10	11.9	16.5	35.1	41.5	19.6
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	76.27	11.8	29.5	-91.2	-11.2	64	107.7	103.3	83.6	43.4	32.5	6.6	12	33.1	33.1	22.2	7.7	12.2	-0.3	12.8	10.5	17.4	0	-7.5	-6.1	2.2	-46	22.9	12.4
balance-sheet.row.total-liabilities-and-total-equity	282.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	4.5	2.8	0	0	28.3	60.6	28.6	9.3	0	0	17.6	14.7	10.4	11.2	13.6	7.4	9.4	6.1	15588.5	10.9	2	0	0	0	3.8	1.7
balance-sheet.row.total-debt	2.33	0.6	0.8	0.9	1.1	0	0.2	0.5	0.8	0.9	0	0	0	0	0	0	1.2	5	5	0	1.3	1.3	4.7	15.4	13.9	7.9	61.2	10.3	1.6
balance-sheet.row.net-debt	-63.1	-11.5	-31.8	-32.3	-39	-71.4	-112.4	-80.2	-25.8	-19.1	-26.3	-10.1	-24.6	-17	-25.4	-45.1	-11.4	-19.6	4.1	-5	-6.3	-3.2	-16.2	13.8	11.3	2.2	58.9	-2.3	-3.7

现金流量表

在 Idera Pharmaceuticals, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
cash-flows.row.net-income	-41.05	-23.4	98.1	-112.7	-56.5	-59.9	-66	-38.4	-48.6	-38.6	-18.2	-19.2	-23.8	-18	7.5	1.5	-13.2	-16.5	-13.7	-12.7	-17.2	17	-5.3	-2.9	-10.5	-17.1	-69.5	-46.9	-34.5	-25.6
cash-flows.row.depreciation-and-amortization	0.01	0	0	0.1	0.1	0.4	0.7	0.7	0.5	0.2	0.1	0.3	0.5	0.5	0.6	0.6	0.3	0.4	0.3	0.3	0.3	0.6	0.2	0.8	2.5	4.3	4.5	2.4	2	1.1
cash-flows.row.deferred-income-tax	-0.27	-6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1.6	-924.5	-99.7	-542.7	1297.4	1297.4	-1850.2	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	2.2	2.5	3.6	3.8	5.7	10.7	6.8	5.4	4.3	1.4	2.1	2.8	3.7	3.1	0	1.6	924.5	99.7	542.7	-1297.4	-1297.4	1850.2	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-0.86	0.3	0.4	-1.1	-3.3	1.3	-1	1.9	-1.2	2.5	-0.6	-2.4	0.8	-6.1	-26.9	18.4	-5.1	17.4	2.6	-0.3	0.2	-28.6	11.9	-6.5	-1.3	-1.2	12.3	2.7	0.2	2.3
cash-flows.row.account-receivables	2	-2.3	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	-0.2	0	117.2	203.4	-131.4	-131.4	-243.4	0	0	0	0	0	0	0
cash-flows.row.inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	-0.3	0	-58.3	-356.4	-24	-59.6	734.4	0	0	0	0	0	0	0
cash-flows.row.account-payables	-2.74	2.5	-1.8	-1.6	-1.1	-0.9	1.7	2	-1.7	2.8	0.1	-2.4	0.2	1.4	0	0	0.9	-251.3	-61.3	139.6	144.9	144.9	-506.4	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	1.7	-0.3	2.1	0.5	-2.2	2.2	-2.7	0	0.5	-0.3	-0.7	0.1	0.6	-12.2	-26.9	18.4	-5.5	268.8	5	13.2	10.7	17.6	27.3	-6.5	-1.3	-1.2	12.3	2.7	0.2	0
cash-flows.row.other-non-cash-items	9.52	2.7	-125.6	76.3	11.3	0.6	0.2	0.7	0.9	0.3	0.2	-0.7	0.5	0.3	0	3	2.2	1.2	0.2	-0.6	2.4	0	6.3	0.8	0.7	-8.6	1.5	-0.4	-0.2	0.8
cash-flows.row.net-cash-provided-by-operating-activities	-29.78	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	0	0	0	0	-0.1	-0.2	-0.4	-0.7	-1.1	0	0	0	-0.1	-0.1	-0.4	-1.6	-0.1	-0.2	-0.1	-0.1	-0.4	-0.1	0	0	-0.5	-7.5	-8.9	0	0
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-14080	403.6	-6396.4	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	0	0	-12.2	-44.5	0	0	-2.9	-63.1	-23.6	-9.3	-1	-1	-10.3	-14.8	-23	-50.5	-26.8	-19.9	-18.6	-17.7	-16	-13.7	-2	0	0	0	-7.5	0	0
cash-flows.row.sales-maturities-of-investments	0	0	4.5	10.5	42.1	0	28.3	34.7	30.4	4.1	0	18.6	18.6	7.2	10.4	23.6	53	20.6	21.9	15.2	29.4	10.9	20.2	0	0	0	3.8	0	0	0
cash-flows.row.other-investing-activites	5.48	5.5	0	0	0	0.3	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0	-0.6	0	14080	-403.6	6396.4	0	11.6	0	6.2	0	0.4	-6.6	-5.1
cash-flows.row.net-cash-used-for-investing-activites	5.48	5.5	4.5	-1.7	-2.4	0.2	28.1	31.4	-33.4	-20.6	-9.3	17.6	17.6	-3.1	-4.3	0.2	0.9	-6.9	1.8	-3.5	11.7	-5.5	6.5	9.6	0	5.7	-3.7	-16	-6.6	-5.1
cash-flows.row.debt-repayment	0	0	0	-0.2	0	-0.2	-0.3	-0.3	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-7.3	-1.6	-0.4	0	0
cash-flows.row.common-stock-issued	0	0	0.2	28.8	15.4	0	53.8	49	80.6	37.1	40.2	0	0	14.1	0	10	1.8	27.9	0.1	15.6	13.1	0.5	0.7	0.2	1.5	6.9	0	55.4	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0	0	0	-5339.5	-5.3	0	0	0	0	0	0	0	41.9	19.8
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	-0.8	-1.1	-0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-1.58	-1.5	19.3	0.1	0.1	10.4	5.7	2.2	2.5	9.3	3.5	6	9.1	0.1	0.3	-1.2	1.1	0	4.6	5338.2	0	-0.4	-1	-3	4.1	20.8	46	10.6	-0.8	1.4
cash-flows.row.net-cash-used-provided-by-financing-activities	-1.58	-1.5	19.4	28.7	15.5	10.2	59.2	50.9	83	45.6	42.7	5.4	9.1	14.2	0.2	8.8	2.9	27.9	4.7	14.3	7.8	0.1	-0.3	-2.8	5.6	20.4	44.4	65.5	41.1	21.2
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	-17.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-25.88	-20.5	-0.7	-6.8	-31.4	-41.5	32	54.1	6.6	-6.3	16.2	-14.5	7.6	-8.5	-19.7	32.6	-12	23.6	-4	-2.6	5.1	-16.4	19.4	-1	-3	3.4	-10.4	7.3	1.9	-5.4
cash-flows.row.cash-at-end-of-period	65.44	12	32.5	33.2	40	71.4	112.6	80.7	26.6	20	26.3	10.1	24.6	17	25.5	45.2	12.6	24.6	1	5	7.6	4.5	20.9	1.5	2.6	5.6	2.2	12.6	1.9	66.1
cash-flows.row.cash-at-beginning-of-period	91.31	32.5	33.2	40	71.4	112.9	80.7	26.6	20	26.3	10.1	24.6	17	25.5	45.2	12.6	24.6	1	5	7.6	2.5	20.9	1.5	2.6	5.6	2.2	12.6	5.3	0	71.4
cash-flows.row.operating-cash-flow	-29.78	-24.5	-24.6	-33.8	-44.5	-51.9	-55.3	-28.2	-43	-31.3	-17.1	-19.9	-19.2	-19.6	-15.6	23.6	-15.8	2.6	-10.5	-13.3	-14.4	-11	13.1	-7.8	-8.6	-22.7	-51.1	-42.1	-32.6	-21.4
cash-flows.row.capital-expenditure	0	0	0	0	0	-0.1	-0.2	-0.4	-0.7	-1.1	0	0	0	-0.1	-0.1	-0.4	-1.6	-0.1	-0.2	-0.1	-0.1	-0.4	-0.1	0	0	-0.5	-7.5	-8.9	0	0
cash-flows.row.free-cash-flow	-29.78	-24.5	-24.6	-33.8	-44.5	-52	-55.5	-28.6	-43.7	-32.4	-17.1	-19.9	-19.2	-19.6	-15.7	23.2	-17.4	2.5	-10.8	-13.4	-14.4	-11.4	13	-7.8	-8.6	-23.1	-58.7	-51	-32.6	-21.4

利润表行

Idera Pharmaceuticals, Inc. 的收入与上期相比变化了 NaN%。据报告, IDRA 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
income-statement-row.row.total-revenue	0	0	0	0	1.4	0.7	0.9	16.2	0.2	0.1	0	0.1	0.1	16.1	34.5	26.4	8	2.4	2.5	0.9	0.9	30.3	0.8	0.3	7	4.5	3.9	4	1.4	1.2
income-statement-row.row.cost-of-revenue	5.67	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.8	-2.5	0	0	0	0	0
income-statement-row.row.gross-profit	-5.67	0	0	0	1.4	0.7	0.9	16.2	0.2	0.1	0	0.1	0.1	16.1	34.5	26.4	8	2.4	2.5	0.9	0.9	30.3	0.8	1.1	9.5	4.5	3.9	4	1.4	1.2
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	15.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	14.73	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	28.55	8.3	1.3	0	0.2	4.4	0	0	0	0	0	0	0	0	0	0	0	0	99.7	0	542.7	6719.5	-4.1	0.8	2.5	0	0	0	0	0
income-statement-row.row.operating-expenses	51.58	32.7	27.7	36.7	47.3	57.3	67.4	55	49.1	38.8	18.2	20	25.9	34.1	27.1	25.9	22.7	19	16.3	13.9	18.3	13.6	7.4	7.6	19.3	27.5	57.9	50.7	35.8	26.7
income-statement-row.row.cost-and-expenses	57.25	32.7	27.7	36.7	47.3	57.3	67.4	55	49.1	38.8	18.2	20	25.9	34.1	27.1	25.9	22.7	19	16.3	13.9	18.3	13.6	7.4	6.8	16.8	27.5	57.9	50.7	35.8	26.7
income-statement-row.row.interest-income	0	0	0	0.2	1.1	1.1	0.6	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0
income-statement-row.row.interest-expense	0.02	0.2	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0.1	0.4	0.3	0	0.1	0.2	1.3	2.2	0	0	0	0	-0.2	-0.1
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-0.02	-0.2	0	-76	-10.4	1.1	0.5	0.4	0.3	0.1	-0.1	0.7	2.1	0	0.1	1	1.5	0	0.1	0.2	0.2	-0.2	0.5	0.1	0	0	-11	0	-0.2	-0.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	28.55	8.3	1.3	0	0.2	4.4	0	0	0	0	0	0	0	0	0	0	0	0	99.7	0	542.7	6719.5	-4.1	0.8	2.5	0	0	0	0	0
income-statement-row.row.total-operating-expenses	-0.02	-0.2	0	-76	-10.4	1.1	0.5	0.4	0.3	0.1	-0.1	0.7	2.1	0	0.1	1	1.5	0	0.1	0.2	0.2	-0.2	0.5	0.1	0	0	-11	0	-0.2	-0.1
income-statement-row.row.interest-expense	0.02	0.2	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0.1	0.4	0.3	0	0.1	0.2	1.3	2.2	0	0	0	0	-0.2	-0.1
income-statement-row.row.depreciation-and-amortization	1.71	1.7	0	0.1	0.1	0.4	0.7	0.7	0.5	0.2	0.1	0.3	0.5	0.5	0.6	0.6	0.3	0.4	0.3	0.3	0.3	0.6	0.2	0.8	2.5	4.3	4.5	2.4	2	1.1
income-statement-row.row.ebitda-caps	-45.91	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-47.62	-29.5	98.1	-36.7	-46.1	-61	-66.5	-38.8	-48.8	-38.8	-18.2	-19.9	-25.9	-18	7.4	0.5	-14.7	-16.6	-13.8	-12.9	-17.4	16.6	-6.6	-6.5	-9.8	-23	-64.9	-46.7	-34.4	-25.5
income-statement-row.row.income-before-tax	-47.64	-29.7	98.1	-112.7	-56.5	-59.9	-66	-38.4	-48.6	-38.6	-18.2	-19.2	-23.8	-18	7.5	1.5	-13.2	-16.5	-13.7	-12.7	-17.2	16.5	-6.1	-6.5	0	0	-75.9	0	-34.5	-25.6
income-statement-row.row.income-tax-expense	-6.59	-6.3	0	-76	-10.4	1.1	0.5	0.4	0.4	0.1	-0.1	0.7	2.1	0	0	0	1.7	0	0.4	0.2	0.3	-0.5	0.5	2.2	0	0	-11	0	-0.3	-0.1
income-statement-row.row.net-income	-41.05	-23.4	98.1	-112.7	-56.5	-59.9	-66	-38.4	-48.6	-38.6	-18.2	-19.2	-23.8	-18	7.5	1.5	-13.2	-16.5	-13.7	-12.7	-17.2	17	-5.3	-2.9	-10.5	-17.1	-69.5	-46.9	-34.5	-25.6